February 2012

Advisor to Pharma-Vinci in the sale to Axellus

ATRIUM has advised the shareholders of Pharma-Vinci in connection with the sale to Axellus, owned by Orkla, which is listed on the Oslo Stock Exchange.

Pharma-Vinci is a Danish pharmaceutical company that develops, manufactures and markets products in dietary supplements, herbal remedies and OTC-pharmaceuticals.

Pharma-Vinci has focused on products in calcium deficiency and products for intimate care for women. The company owns, among others the market-leading brands UniKalk, Vivag, Canvag, Intima and BioVinci. Axellus take all Pharma-Vinci products into its Northern European distribution channel and expect significant sales.

ATRIUM has been in contact with most big pharma manufacturers, as well as a number of international OTC and VMS manufacturers.

"The ATRIUM team has been an excellent partner throughout the sales process. Truly dedicated, commercial and productive"

Klaus Baagøe-Nielsen, CEO

Back
Transactiontype
Sale
Year
2012
Trade Value
DKK 112 mio.
Process
Auction
Industry
Healthcare